1. Home
  2. HFWA vs EYPT Comparison

HFWA vs EYPT Comparison

Compare HFWA & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Financial Corporation

HFWA

Heritage Financial Corporation

HOLD

Current Price

$29.66

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$12.21

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFWA
EYPT
Founded
1927
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
1997
2005

Fundamental Metrics

Financial Performance
Metric
HFWA
EYPT
Price
$29.66
$12.21
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$30.50
$31.80
AVG Volume (30 Days)
397.9K
1.5M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.53%
N/A
EPS Growth
58.06
N/A
EPS
0.48
N/A
Revenue
N/A
$7,539,000.00
Revenue This Year
$45.85
N/A
Revenue Next Year
$7.83
$3,115.57
P/E Ratio
$61.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.32
$9.41
52 Week High
$31.25
$19.11

Technical Indicators

Market Signals
Indicator
HFWA
EYPT
Relative Strength Index (RSI) 48.27 42.00
Support Level $28.87 $11.81
Resistance Level $30.92 $13.32
Average True Range (ATR) 0.74 0.84
MACD -0.16 -0.13
Stochastic Oscillator 21.06 17.42

Price Performance

Historical Comparison
HFWA
EYPT

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company, through its subsidiary, provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as non-interest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

Share on Social Networks: